The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Young Arthur is just 17 months old and is facing a lengthy stay at Great Ormond Street hospital ...
Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...
“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...
Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.